Skystar Bio Pharmaceutical Co. (SKBI) Reports Q1 EPS of $0.09

Skystar Bio Pharmaceutical Co. (NASDAQ: SKBI) reported Q1 EPS of $0.09, versus $0.26 reported last year. Revenue for the quarter came in at $5.53 million, versus $7.93 million reported last year.

For earnings history and earnings-related data on Skystar Bio Pharmaceutical Co. (SKBI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Portland General Electric halts holding company restructuring plan
• Gates acquires Timken's belts business, adding Mexico facility